Safety and Feasibility of DBS for Bipolar Depression
This study addresses a critical unmet need in the treatment of bipolar disorder by
investigating whether Subcallosal Cingulate (SCC) Deep Brain Stimulation (DBS) can safely
and effectively treat treatment-resistant bipolar depression without inducing manic
switches. ...
Age: 22 - 70 years
Gender: All
Natural History of MADD
The objective of this study is to conduct a longitudinal, observational investigation to
determine the natural history of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD),
delineate the spectrum of its clinical features and their progression, identify
biomarkers, an...
Age: Birth - 66+
Gender: All
Delayed Toxicities Post-CAR-T
This is an observational umbrella protocol evaluating toxicities after CAR-T therapy with
ciltacabtagene autoleucel (cilta-cel) for RRMM, with a goal to identify key inflammatory
features contributing to toxicities, define non-invasive biomarkers to guide clinical
mo...
Age: 18 years - 66+
Gender: All
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
The main aim of the study to describe the characteristics of participants with asthma
across the spectrum of disease severity, including sociodemographic and clinical
characteristics, treatment and disease burden, biomarkers, and both disease-specific and
generic hea...
Age: 6 years - 66+
Gender: All
Study of Oral Food Challenge Biomarkers (SAFER)
This is a multi-center, mechanistic study. It is designed to learn more about signs in
the body, called biomarkers, that might show if someone will have a reaction to peanut
during a feeding test. The trial will enroll children ages 12 months to17 years old who
are s...
Age: 12 months - 17 years
Gender: All
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
The goal of this clinical trial is to learn how tests undertaken by people at high risk
of developing psychosis (aged 17 to 30 years old) change when those people are given the
study drug MT1988 daily for 8 weeks. This will help identify tests that could be used in
l...
Age: 17 - 30 years
Gender: All
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Rationale: LTI-03 is an experimental medication breathed into the lungs using an inhaler.
It is being studied for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is a
progressive, fatal lung disease caused by the death of lung cells involved in oxygen
uptak...
Age: 40 years - 66+
Gender: All
Research Infrastructure for the study of Alzheimer’s Disease and Alzheimer’s Disease related dementias in older Asian Americans
By phone, contact: Cantonese/English: 929-504-2324 | Mandarin/English: 917-656-4981
The purpose of this research study is to understand the influence of social factors and blood-based biomarkers in older Asian American adults across their cognitive status, includin...
Age: 55 - 99 years
Gender: All
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
The goal of this observational study is to understand how genomic and epigenetic factors
contribute to resistance against chemo-immunotherapy in adults diagnosed with
extensive-stage small cell lung cancer (ES-SCLC) or metastatic large cell neuroendocrine
carcinoma (...
Age: 18 - 85 years
Gender: All
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
J8G-MC-JDIA (AJX-101) is a first-in-human (FIH), phase 1, non-randomized, multi-center,
open-label clinical trial designed to investigate the safety, tolerability,
pharmacokinetics (PK), clinical activity and changes in biomarkers of an orally
administered type II Ja...
Age: 18 years - 66+
Gender: All
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
The Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts
(ESSENTIAL) study is a 5-year, multicenter randomized open-label trial that will screen
400 cognitively normal older adults recruited from well-established sleep clinics at 4
academic...
Age: 55 - 85 years
Gender: All
DBS for TRD With the Medtronic Percept PC
Of the estimated 30 million Americans who suffer from Major Depressive Disorder,
approximately 10% are considered treatment resistant. Deep brain stimulation (DBS) to a
region of the brain called the subcallosal cingulate (SCC) is an emerging strategy for
treatment r...
Age: 25 - 70 years
Gender: All
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
This study collects blood and tissue samples for research of human immunodeficiency virus
(HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and
tissue samples and studying biomarkers in the laboratory may help doctors to learn how
are ...
Age: 18 years - 66+
Gender: All
A Multi Center Study of Sexual Toxicities After Radiotherapy
The purpose of this research is to understand how radiotherapy and other cancer
treatments impact sexual function in female cancer patients and to try to answer a
question about why some patients who receive radiotherapy are more likely to have side
effects than othe...
Age: 18 years - 66+
Gender: Female
Human Epilepsy Project 3
By carrying a careful, large-scale and ambitious prospective study of a cohort of
participants with generalized epilepsy, the study team hopes to clarify the likelihood of
response and remission in this type of epilepsy, and try to explore the underlying biological
...
Age: 13 years - 66+
Gender: All
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute
ischemic stroke window for immediate use in clinical trials, and explore these biomarkers
in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale,
pros...
Age: 18 years - 66+
Gender: All
MINDS Imaging Ancillary Study
This study is an ancillary study to the NHLBI-funded Pediatric Heart Network (PHN)
"Multi-Institutional Neurocognitive Discovery Study" (MINDS) in Adult Congenital Heart
Disease (ACHD). The MINDS-ACHD" study will recruit 500 complex CHD patients between18-30
years...
Age: 18 - 30 years
Gender: All
Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients
Novel invasive neurostimulation stimulation strategies through neurosurgical
interventions are emerging as a promising therapeutical strategy for major depressive
disorder. These have been applied mostly to the anterior cingulate cortex, but other
limbic brain region...
Age: 18 - 80 years
Gender: All
Environmental Factors and Thyroid Cancer
Thyroid cancer incidence has been steadily increasing and has nearly tripled since the
1970's in the US and worldwide. Early detection of small, papillary thyroid cancers using
high quality diagnostic imaging explains only about 50% of this increased incidence,
sugge...
Age: 18 years - 66+
Gender: All
Renal Allograft Fibrosis Study
Despite the reduction in acute rejection episodes in renal transplant patients due to
modern immunosuppression, proportionate improvements in long-term allograft survival have
not been achieved. Virtually any disease or injury affecting renal allografts can
culminate...
Age: 18 years - 66+
Gender: All